Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
about
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDOxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosisRole of diet and lifestyle changes in nonalcoholic fatty liver diseaseThe hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis.Glucose intolerance and the amount of visceral adipose tissue contribute to an increase in circulating triglyceride concentrations in Caucasian obese females.Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis.Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications.Association between retinal artery lesions and nonalcoholic fatty liver diseaseEvaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease.From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center.Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease.The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart StudyDyslipidemia in patients with nonalcoholic fatty liver disease.Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery diseaseRelationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD)Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies.Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review.Molecular mechanisms of hypolipidemic effects of curcumin.Adipocytokines and hepatic fibrosis.SNPs affecting serum metabolomic traits may regulate gene transcription and lipid accumulation in the liver.Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.Non-alcoholic fatty liver disease is associated with benign prostate hyperplasia in men and with overactive bladder in women.Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.Time-dependent cellular response in the liver and heart in a dietary-induced obese mouse model: the potential role of ER stress and autophagy.
P2860
Q26752487-E7B9DA02-13A8-44E0-BF41-9ADC181AD7AAQ28084150-AF01F3A2-DE9A-448A-A9C9-21FBB3D63004Q33948329-6ECB6C5A-C42F-4200-8A91-76DF1EDA6881Q34303169-B84DFF9B-C538-49F8-90ED-25CF92022E55Q34311151-7051329E-790D-4275-A3AF-BC789ED88AE2Q34428207-9409FEC3-8A7C-42DD-B2A0-3437451B7FE1Q34729697-F1450AF6-636D-4259-B7AF-286DC45BAACFQ35084719-7DFB025C-B496-4DB4-ABBB-E1B0E6E6C2EDQ35289060-C568CC67-4A9E-4189-9A38-AF4ABFA2EB8AQ35560585-90DC29AA-605C-4794-85C7-6952CF607016Q36207195-00A0E44C-CA7F-4159-81F2-AA5072046BC0Q36473562-BCE3E586-BE8F-4D3F-84C0-19146E52303BQ36699028-230D673A-C9C0-4934-8F4A-21B761AF1D04Q36807854-BF0BBF88-C579-44E1-8CD9-7D79F50D3E87Q36845703-71AFC759-B1E9-4FE1-9F01-A4672709E809Q37133722-A6CAE8A8-6C7D-4B4E-8F43-8E5511FB90ABQ37175334-6E96E4AE-D9DD-4AE0-AF30-30C8DE7F21C6Q37993779-A79D9A3E-0050-49F5-BCE1-8B1CE6A97C8CQ38074826-AAC87C9E-B2A0-4089-9F41-C11498956B75Q38075862-CDDA2600-81A0-4DFD-81F7-B99F1B8D00D0Q38346026-8B94E8AB-24B1-438A-973D-F3CECC8B4999Q42787595-9C3134CF-FE35-4DEB-A7BB-24B0AFCB8B26Q44324185-C7B8B3BB-F1B4-464C-A4E7-CF5AED6EF072Q45901789-C8D6CE2E-A48A-41F9-80EF-69C2F2A5C3D5Q47156332-418C91B0-93E3-4396-8002-8FC347354903Q53388015-4D61076D-1D1F-436D-B0CC-93F667E93C23
P2860
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
@en
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
@nl
type
label
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
@en
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
@nl
prefLabel
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
@en
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
@nl
P2093
P2860
P1476
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10620-011-1767-Y
P577
2011-06-08T00:00:00Z